ZDGGF yields 2030.46% · JNJ yields 2.13%● Live data
📍 ZDGGF pulled ahead of the other in Year 1
Combined, ZDGGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZDGGF + JNJ for your $10,000?
ZOO Digital Group plc, through its subsidiaries, provides cloud-based localisation and digital distribution services in the United Kingdom and the United States. It operates through two segments, Media Production, and Software Solutions. The company offers localisation services, including subtitling, scripting, dubbing, audio postproduction, and audio description; media services, such as content preparation, digital packaging/post-production, and metadata preparation; and asset health check services. It also provides various platforms, such as ZOOstudio, a secure platform that provides centralised system to manage localisation and media service operations; ZOOdubs, an end-to-end dubbing platform; ZOOsubs, a subtitling platform that enables talented translators to deliver perfect subtitles; ZOOscripts, a cloud-based scripting platform that provides centralized and accurate script reference for all localization workflows; and ZOOsign, a cloud-based dubbing contract management platform that manages dubbing contracts and assignment of rights. In addition, the company offers localization and media services to the media and entertainment industry. ZOO Digital Group plc was incorporated in 1999 and is headquartered in Sheffield, the United Kingdom.
Full ZDGGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.